Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4726
CALL
Community Health Systems
CYH
$419M
| $254K | ﹤0.01% |
73,300
+25,200
| +52% | +$82K |
|
4727
Gates Industrial Corporation Ltd.
GTES
$7B
| $254K | ﹤0.01% |
13,019
+11,290
| +653% | +$197K |
|
4728
Independent Bank Corp
IBCP
$854M
| $254K | ﹤0.01% |
10,773
+6,325
| +142% | +$158K |
|
4729
Kopin
KOPN
$898M
| $254K | ﹤0.01% |
105,194
+80,528
| +326% | +$205K |
|
4730
Midland States Bancorp
MSBI
$698M
| $254K | ﹤0.01% |
7,909
+6,365
| +412% | +$219K |
|
4731
Expro Ltd
XPRO
$2.1B
| $254K | ﹤0.01% |
4,877
+3,983
| +446% | +$201K |
|
|
SMAR
4732
DELISTED
Smartsheet Inc.
SMAR
| $254K | ﹤0.01% |
8,141
-1,155
| -12% | -$30.8K |
|
|
EIGI
4733
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $254K | ﹤0.01% |
28,882
+23,682
| +455% | +$225K |
|
4734
Immersion
IMMR
$248M
| $253K | ﹤0.01% |
23,833
-41,458
| -63% | -$518K |
|
4735
Citi Trends
CTRN
$621M
| $252K | ﹤0.01% |
8,746
+1,513
| +21% | +$44.7K |
|
4736
CALL
iShares MSCI Australia ETF
EWA
$1.45B
| $252K | ﹤0.01% |
11,400
+7,300
| +178% | +$164K |
|
|
TBHC
4737
DELISTED
The Brand House Collective
TBHC
| $252K | ﹤0.01% |
24,895
+11,820
| +90% | +$128K |
|
4738
PUT
Morningstar
MORN
$7.76B
| $252K | ﹤0.01% |
+2,000
| New | +$270K |
|
4739
Tilly's
TLYS
$122M
| $252K | ﹤0.01% |
13,296
+12,166
| +1,077% | +$209K |
|
|
VBTX
4740
DELISTED
Veritex Holdings
VBTX
| $252K | ﹤0.01% |
8,908
+7,205
| +423% | +$221K |
|
|
CRZO
4741
PUT
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $252K | ﹤0.01% |
10,000
-90,900
| -90% | -$2.35M |
|
|
APLS
4742
DELISTED
Apellis Pharmaceuticals
APLS
| $251K | ﹤0.01% |
14,054
+11,406
| +431% | +$211K |
|
4743
CALL
Avnet
AVT
$7.87B
| $251K | ﹤0.01% |
5,600
+2,300
| +70% | +$106K |
|
4744
PUT
Enviri
NVRI
$564M
| $251K | ﹤0.01% |
8,800
+4,300
| +96% | +$111K |
|
4745
CALL
ProShares UltraShort Bloomberg Crude Oil
SCO
$605M
| $251K | ﹤0.01% |
233
-127
| -35% | -$162K |
|
|
PFC
4746
DELISTED
Premier Financial Corp. Common Stock
PFC
| $251K | ﹤0.01% |
8,333
+6,285
| +307% | +$202K |
|
|
UNVR
4747
DELISTED
Univar Solutions Inc.
UNVR
| $251K | ﹤0.01% |
8,187
-12,994
| -61% | -$362K |
|
|
KBAL
4748
DELISTED
Kimball International
KBAL
| $251K | ﹤0.01% |
14,999
+5,650
| +60% | +$96K |
|
4749
FerroAtlántica
GSM
$818M
| $250K | ﹤0.01% |
30,557
+11,479
| +60% | +$91.8K |
|
4750
Inspire Medical Systems
INSP
$1.68B
| $250K | ﹤0.01% |
5,930
+5,355
| +931% | +$251K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.